Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $707,555 - $1.03 Million
-3,641 Reduced 54.11%
3,088 $615,000
Q2 2023

Jul 27, 2023

BUY
$223.05 - $302.68 $1.5 Million - $2.04 Million
6,729 New
6,729 $1.92 Million
Q4 2022

Feb 15, 2023

BUY
$204.38 - $296.82 $177,401 - $257,639
868 Added 52.38%
2,525 $519,000
Q3 2022

Nov 07, 2022

BUY
$195.21 - $310.53 $323,462 - $514,548
1,657 New
1,657 $461,000
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $280,914 - $403,531
-1,713 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$131.45 - $201.49 $225,173 - $345,152
1,713 New
1,713 $325,000
Q1 2021

May 19, 2021

SELL
$92.73 - $142.05 $179,525 - $275,008
-1,936 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$67.44 - $103.72 $130,563 - $200,801
1,936 New
1,936 $201,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.